New cholesterol drug put to the test in healthy volunteers
NCT ID NCT07319559
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called DW5124 in 55 healthy adults to see how safe it is and how the body processes it. Researchers also checked whether taking the drug with food changes its effects. The goal was to gather basic information before testing the drug in people with high cholesterol.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New cholesterol drug showdown: could obicetrapib beat bempedoic acid?
- New injection shows promise for lowering cholesterol in indian patients
- New cholesterol drug AD-117: does food change how it works?
- Triple-Drug cocktail aims to reverse early heart disease
- New pill combo aims to crush high cholesterol
- Massive Real-World study checks cholesterol Drugs' effectiveness in china